Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

121
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
121

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Efficacy of Endovascular Revascularization Modalities for Symptomatic Infrapopliteal Peripheral Artery Disease: A Network Meta-Analysis.

JACC. Cardiovascular interventions·2026
Same author

Balloon-Assisted Translocation of the Mitral Anterior Leaflet to Prevent Outflow Tract Obstruction During TMVR: The BATMAN Registry.

JACC. Cardiovascular interventions·2026
Same author

Patency Without Payoff: Reassessing Endpoints in Infrapopliteal Peripheral Artery Disease.

Journal of the American College of Cardiology·2026
Same author

Safety of same-day discharge after mitral transcatheter edge-to-edge repair.

Journal of cardiology·2026
Same author

Characterizing the association of heparin dose and activated clotting time on lower extremity bypass outcomes.

Journal of vascular surgery·2026
Same author

Temporal Trends in Isolated and Concomitant Aortic Valve Replacement for Aortic Stenosis in Patients Aged <65 Years.

Circulation. Cardiovascular interventions·2026

Related Experiment Video

Updated: Jun 17, 2025

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.4K

In-hospital Outcomes and Cost Associated With Treatments for Non-ST-elevation Myocardial Infarction.

Fabio V Lima1, Kevin F Kennedy2, Marwan Saad1

  • 1Cardiovascular Institute, Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Journal of the Society for Cardiovascular Angiography & Interventions
|August 12, 2024
PubMed
Summary

Outcomes for non-ST-elevation myocardial infarction (NSTEMI) vary significantly by hospital and treatment strategy. This study found considerable differences in patient outcomes, length of stay, and costs, even after accounting for patient and hospital factors.

Keywords:
coronary artery bypass graft surgerynon–ST-elevation myocardial infarctionpercutaneous coronary interventionvariation

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

387
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.2K

Related Experiment Videos

Last Updated: Jun 17, 2025

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.4K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

387
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.2K

Area of Science:

  • Cardiology
  • Health Services Research
  • Outcomes Research

Background:

  • Management of non-ST-elevation myocardial infarction (NSTEMI) varies widely across US hospitals.
  • Limited data exist on outcome variations linked to specific NSTEMI management strategies.

Purpose of the Study:

  • To characterize variations in clinical outcomes, length of stay (LOS), and costs associated with different NSTEMI treatment strategies.
  • To analyze hospital-level variations in outcomes following medical therapy, angiography, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG).

Main Methods:

  • Analysis of 140,194 NSTEMI hospitalizations from the National Inpatient Sample (2016-2018).
  • Patients categorized by treatment: medical therapy alone, angiography without revascularization, PCI, or CABG.
  • Primary endpoint: composite of in-hospital death, postprocedure myocardial infarction, or stroke; secondary endpoints: LOS and cost.
  • Variation characterized by median odds ratio, adjusting for patient and hospital factors.

Main Results:

  • Significant variation in the composite outcome was observed: patients undergoing PCI were 25% more likely, and those undergoing CABG were 45% more likely, to experience adverse events at some hospitals compared to others.
  • Hospital-level variations in LOS and cost were also significant across all treatment modalities.
  • Treatment distribution: 25.5% medical therapy, 20.5% angiography only, 41.6% PCI, 12.4% CABG.

Conclusions:

  • Substantial hospital-level variation exists in clinical outcomes, LOS, and costs for NSTEMI patients, irrespective of the treatment strategy.
  • These variations persist even after adjusting for patient and hospital characteristics, highlighting potential areas for quality improvement.